AI developed for staging patients with prostate cancer

Nicolo Capobianco, PhD, a research scientist at Siemens Healthineers in Erlangen, Germany, and colleagues at the Lawson Health Research Institute in London, Ontario, developed a model that identifies regions suspicious for cancer and that agreed with a physician expert.

“The proposed method is promising to support prostate cancer staging based on PSMA-ligand PET/CT,” Capobianco told attendees in a June 24 session on basic and translational oncology research.

In recent years, researchers have developed PET radiotracers that reveal prostate cancer based on their ability to bind to…